Connect with us

Featured

Premier Health (OTC:PHGRF) (CSE:PHGI) Signs Definitive Agreement for Acquisition of Cloud Practice Inc., a National Medical Software Application Company

Joe Samuel

Published

on

  • Cloud Practice Inc. products include: Juno EMR, a cloud based EMR solution; ClinicAid, a medical billing software; and MyHealthAccess, an online patient portal
  • The Juno EMR system is currently used by 287 clinics, over 3,000 licensed practitioners, 1,500 staff and 2,870,000 registered patients
  • Cloud Practice services over 60 Cannabis Clinics with over 120,000 active patients.
  • ClinicAid processes upwards of $30,000,000 in payments to over 3000 health providers on a monthly basis

VANCOUVER, British Columbia, January 10, 2018 – Premier Health Group Inc. (CSE: PHGI, OTCQB: PHGRF, Frankfurt: 6PH) (the “Company” or “Premier Health”), a Company focused on developing innovative approaches that combine human skill based expertise with emerging technologies for the healthcare industry, is pleased to announce, further to its news release dated December 17, 2018, the Company has signed a Definitive Agreement (“the Agreement”) to acquire all of the outstanding securities of Cloud Practice Inc. (“Cloud Practice”).

EXCLUSIVE: Multi-Trillion Dollar Industry Providing Massive Opportunity in 2019 & Beyond

Cloud Practice’s founders, including CEO Jordan Visco, and entire support team, consisting of several software developers and sales staff, will join and work alongside the Premier Health team to offer tools and resources providing for better efficiency on a day-to-day basis for both physicians and customers. The combined Premier and Cloud Practice ecosystem consists of over 3,000,000 patients.

“We are very excited to have completed this acquisition and to have the experienced team at Cloud Practice join the team at Premier Health. With this acquisition, we now have a medical software company with national reach. Thus, enabling us to build on our patient centric technology platform that will integrate telemedicine, online booking and other premium services with our electronic medical records (EMR) system,” said Dr. Essam Hamza, CEO of Premier.

Jordan Visco, CEO of Cloud Practice, stated: “We are thrilled to be joining a progressive group such as Premier Health. We are focused on delivering top quality service to Canada’s healthcare industry and we are confident that with Cloud Practice’s offerings combined with the Premier Health teams’ expertise and long-term vision, we can achieve considerable success.”

In consideration for the acquisition of all of the outstanding Cloud Practice securities, Premier will pay to the Cloud Practice shareholders total consideration of up to $5 million as follows: (i) $500,000 paid in cash on signing of the binding LOI as a refundable deposit, (ii) $500,000 in cash payable on closing, (iii) $500,000 in cash payable 90 days after closing, (iv) $500,000 in cash payable within six months of the LOI subject to the satisfaction of certain milestones related to the integration of the Juno EMR, and (v) an aggregate of $3 million payable in common shares of Premier at a deemed price of $0.76 per share.

All shares issued in the transaction are subject to a restricted period of four months and one day. There were no finder’s fees paid in connection with the Transaction.

ON BEHALF OF THE BOARD OF DIRECTORS

“Dr. Essam Hamza, MD”

Chief Executive Officer

 

About Premier Health

 

Premier Health is a Canadian company that is strategically poised to take advantage of business opportunities in the global health care industry. We are developing innovative health care approaches that combine human skill based expertise with emerging technologies, with the goal of setting the gold standard for services in locations of interest worldwide. Premier Health’s subsidiary, HealthVue is focused on developing proprietary technology to deliver quality healthcare through the combination of connected primary care clinics with telemedicine and artificial intelligence (AI). We currently have an ecosystem of over 100,000 active patients and have plans to rapidly increase that number both domestically and internationally. The HealthVue team has a strong track record of successfully creating value in healthcare and technology enterprises. The Management team has deep clinical, financial and operational expertise and a passion for improving healthcare for all patients.

 

About Cloud Practice

 

Cloud Practice is a cloud-based software solutions company focused on streamlining medical practice throughout Canada. They offer three products including Juno EMR, ClinicAid and MyHealthAccess. Juno EMR, a modified branch of an open-source electronic medical records (EMR) software which was originally released by McMaster University, is hosted in the cloud and can be accessed anywhere, anytime. ClinicAid is Canada’s easiest medical billing software. MyHealthAccess is an online patient portal which puts patients back in control of their health care through connecting with their clinics and booking appointments online.

Cautionary Statements

This news release contains forward-looking statements that are based on Premier Health’s expectations, estimates and projections regarding its business and the economic environment in which it operates, including with respect to its business plans, completion of its acquisition of Cloud Practice, and the timing thereof, the expected benefits to the Company following the integration of Cloud Practice’s software and the expected implementation of new applications, including the timing thereof, the expect growth to Cloud Practice’s business and the expected synergies resulting from the Company’s acquisition of Cloud Practice. Although Premier Health believes the expectations expressed in such forward-looking statements are based on reasonable assumptions, such statements are not guarantees of future performance and involve risks and uncertainties that are difficult to control or predict. Therefore, actual outcomes and results may differ materially from those expressed in these forward-looking statements and readers should not place undue reliance on such statements. These forward-looking statements speak only as of the date on which they are made, and Premier Health undertakes no obligation to update them publicly to reflect new information or the occurrence of future events or circumstances, unless otherwise required to do so by law.

The Canadian Securities Exchange does not accept responsibility for the adequacy or accuracy of this release.

FOR ADDITIONAL INFORMATION CONTACT:

Premier Health Group Inc.

www.mypremierhealth.com

Email: investors@mypremierhealth.com

Pursuant to an agreement between MIDAM VENTURES, LLC and Premier Health Group Inc. we were hired for a period from 10/1/2018 – 4/1/2019 to publicly disseminate information about Premier Health Group Inc. including on the Website and other media including Facebook and Twitter. We were paid $300,000 ( CASH) for & were paid “500,000” shares of restricted common shares (as of 1/2/2019). We own zero shares of Premier Health Group Inc., which we purchased in the open market. Once the (6) Six-month restriction is complete on 4/1/2019 we plan to sell the “500,000” shares of Premier Health Group Inc. that we hold currently in restricted form during the time the Website and/or Facebook and Twitter Information recommends that investors or visitors to the website purchase without further notice to you. We may buy or sell additional shares of Premier Health Group Inc. in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click here for full disclaimer.

Continue Reading
Click to comment

Featured

Can Apple (AAPL) Stock Price Catch A Boost From AppleTV+?

Daniel Chase

Published

on

apple stock price AAPL

Apple Inc. (AAPL Stock Report) is growingly shifting its dependence on other categories of products as iPhone sales continue the decline. The biggest bets for the company involve services and at the beginning of the year, they introduced four new services that are Apple News+, The Apple Card, Apple Arcade and the Apple TV+.

Apple TV plus to debut in November

One of the services Apple TV+ subscription is expected to be launched in two months and it is seen as a competitor to streaming platform Netflix Inc. (NASDAQ: NFLX). For over two years Apple has been planning its entry into the TV subscription space. Early reports indicated that the company was planning to commit over $1 billion on programming to realize the venture.

The company plans to introduce a small collection of shows before expanding its catalog in months to follow. Sources familiar with the matter indicated that there is a possibility a free trial as the company continues to build its library. Apple will employ a different video subscription strategy for its shows with plans of offering the first three episodes of shows then followed by weekly installments.

Tech Stocks That Could Benefit From The Boom In New Streaming Stocks

The “Netflix and Chill” or now “Apple And Chill?” mentality of the new generation of viewers may have created an opportunity for certain niche sectors. One of these niche’s is on-demand delivery stocks. Amazon and Uber have entered the space with a significant focus on timeliness. However, as Uber puts it, UberEats may be the loss leader for the company due to the infrastructure. Furthermore, Amazon may be more insulated due to the sheer size of its core business.

This being said, it’s vital to look at companies that may be smaller, more nimble, and streamlined for potential profitability. In this regard, ParcelPal (PTNYF) (PKG) has been a company that we’ve discussed numerous times in the past. The company targets on-demand delivery of pretty much anything. But what has set it apart from the UberEats and Postmates of the world is their direct integration of cannabis.

Something that is beginning to set ParcelPal (PTNYF) (PKG) apart from its immediate competition is its diversification strategy. Not only is the company working with the likes of Amazon, but it is also entering into key verticals that are seeing an increase in rapid demand. Right now, ParcelPal (PTNYF) (PKG) has built relationships with businesses in both alcohol and cannabis.

We don’t have to go into the deep details of these booming industries, but it is vital to understand that the evolution from brick-and-mortar to on-demand delivery could be setting the stage for a major economic boom.

While consumers are becoming more comfortable with using smartphones and computers to buy groceries, they are also increasingly using the same technology to help them skip trips to the liquor store, according to data from the e-commerce analytics firm, Slice Intelligence. Netflix and Chill just got an upgrade!

Joining the competitive streaming space

Apple joins the growing number of providers offering streaming services such as Netflix, and Amazon.com Inc. (AMZN Stock Report), Walt Disney Co. (NYSE: DIS),Comcast Corp.’s (CMCSA Stock Report) NBCUniversal and AT&T Inc. (T Stock Report). These companies are all targeting the growing number of viewers who are watching on mobile devices or canceling cable TV subscriptions. 

The company has set aside $6 billion of its budget for the rolling out of TV+ subscription’s shows and movies. Apple is spending more money as it attempts to create more to achieve its goal of $50 billion in service sales by next year. The company is seeking new ways of generating revenue as smartphone sales continue to slow down due to market saturation and weak economies. 

Apple has not indicated the pricing of the service but it is expected to be around $9.99 per month. Netflix and Amazon charge $8.99 while Disney+ will charge $6.99 when its service becomes available in November.

apple stock price AAPL
Disclaimer: MIDAM VENTURES LLC has been compensated $75,000 per month by a ParcelPal Technology, Inc. for a period beginning September 1, 2018 and ending February 1, 2019 to publicly disseminate information about (PTNYF/PKG) to publicly disseminate information about (PTNYF/PKG). Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to April 1, 2019. Midam Ventures has been compensated $100,000 by Parcel Pal and has extended coverage to May 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to June 1, 2019. Midam Ventures has been compensated $200,000 by Parcel Pal and has extended coverage to July 1, 2019. We may buy or sell additional shares of (PTNYF/PKG) in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. We own zero shares. Click Here For Full Disclaimer

Continue Reading

Featured

Stock Price Wednesday Morning Update – August 21, 2019

Joe Samuel

Published

on

biotech stocks to watch

PharmaCyte Biotech to Hold Special Shareholder Meeting

PharmaCyte Biotech, Inc. (PMCB), a clinical-stage biotechnology company focused on developing targeted cellular therapies for cancer and diabetes using its signature live-cell encapsulation technology, Cell-in-a-Box®, today announced that it will hold a Special Shareholder Meeting on September 11, 2019.

See More On This – CLICK HERE


Must Read Biotech Stock Report

With a wave of groundbreaking products in the pipeline, biotechnology could be poised to keep churning higher for the foreseeable future. But how can you get in on the ground floor of the next big wave in biotech?

Continue Reading


2 Food Delivery Stocks To Watch Before The End Of Summer

The food delivery industry in the United States has grown into a behemoth and although the margins are extremely thin, investors are willing to bet billions on some of the biggest food delivery companies. At this point in time, companies are fighting among themselves to gain supremacy in this space and competition is heating up as they look to grab market share from each other.

Read More Here


2 Chinese Stocks Making Bullish Moves

The trade war with the United States and an economic slowdown for the first time in three decades has cratered the markets in China. China-based stocks have generally underperformed over the course of the past year. But even during such a slowdown, some stock prices have been showing bullish tendencies. Here is a look at two such China-based companies that have seen stock prices climb.

See For Yourself

biotech stock to buy 2019

Disclaimer: Pursuant to an agreement between MIDAM VENTURES, LLC and Complete Investment And Management LLC, a Non-affiliate Third Party, Midam was hired for a period from 07/09/2019 – 8/09/2019 to publicly disseminate information about PharmaCyte Biotech including on the Website and other media including Facebook and Twitter. We were paid $150,000 (CASH) for & were paid “0” shares of restricted common shares. We were paid an additional $150,000 (CASH) BY Complete Investment And Management LLC, a Non-affiliate Third Party, AND HAVE EXTENDED coverage for a period from 8/12/2019 – 9/12/2019. We may buy or sell additional shares of PharmaCyte Biotech in the open market at any time, including before, during or after the Website and Information, provide public dissemination of favorable Information. Click Here For Full Disclaimer

Continue Reading

Featured

2 Chinese Stocks Making Bullish Moves

A. Lawrence

Published

on

chinese stock prices

The trade war with the United States and an economic slowdown for the first time in three decades has cratered the markets in China. China-based stocks have generally underperformed over the course of the past year. But even during such a slowdown, some stock prices have been showing bullish tendencies. Here is a look at two such China-based companies that have seen stock prices climb.

SINA Corp (SINA)

One of the stocks that recorded significant gains on Monday was that of SINA Corp (SINA Stock Report), the Chinese digital media company. The company announced its quarterly earnings yesterday and results proved to be hugely impressive. The company’s earnings for Q2 2019 stood at an impressive $0.73 per share while total sales rose to $533.1 million. It managed to beat analysts’ expectations of earnings of $0.47 per share and sales of $510.2 million in sales handsomely.

[Read More] 2 Food Delivery Stocks To Watch Before The End Of Summer

That being said, it needs to be pointed out that the company’s sales figures had actually declined by 1% year on year. However, the fact that it managed to beat estimates has proven to be a major trigger for the SINA stock. On Monday, the stock gained as much as 13% and should be in focus for the rest of the week.

Baidu Inc (BIDU)

The other Chinese stock that surged on Monday was that of tech giant Baidu Inc (BIDU Stock Report), which, like SINA, had managed to deliver better than expected earnings. The company had a disappointing Q1 2019 but has managed to bounce back in the second quarter by generating $3.83 billion in revenues and earnings per share of $1.47. The results also managed to beat the projections that the company had provided some months ago.

Considering the fact that the Chinese economy is currently in a slowdown, this is an acceptable earnings results for Baidu and hence the company’s stock rose by as much as 9% yesterday. It would be worthwhile to keep an eye on the stock for the foreseeable future.  

Continue Reading

Join Our Newsletter

Get stock alerts, news & trending stock alerts straight to your inbox!


We keep all user information pricate & promise to never spam.*

Privacy Policy

Search Stock Price (StockPrice.com)




Trending

Subscribe Now & Begin Receiving Free Stocks News, Articles, Trade Alerts & MORE, all 100% FREE!

We are your #1 source for all things Stock Market & Finance, Subscribe Below!

Privacy Policy: We will NEVER share, sell, barter, etc. any of our subscribers information for any reason ever! By subscribing you agree we can send you via email our free e-newsletter on stock market & finance related, articles, news and trade alerts. Further questions please contact privacy@stockprice.com